The European Medicines Agency (EMEA) has recommended that the appetite suppressant sibutramine, also known as Reductil, should no longer be prescribed by doctors and that pharmacists should no longer dispense the drug...Too bad.
The regulator has been conducting a review of safety and has concluded the increased risks of heart attacks and strokes do not outweigh the benefits.
A trial of 10,000 patients followed for six years comparing sibutramine to a placebo has not yet been reported but the regulator warned that heart attacks and strokes were more common in those taking the drug. People taking the drug only achieved modest weight loss when compared to those on a placebo, the report from the European Medicines Agency said.
Diabetes UK Care Advisor Caroline Butler said: "Following recommendations from the EMEA, we would advise people with diabetes who are overweight and taking sibutramine to see their GP or healthcare professional to discuss an alternative weight loss drug.
Fitness Watch is your site for making sense of fitness advice.
"Truth" has a shelf life.
The shelf life of "truth" is very short in the domains of fitness, health and well-being.
The reason is that so much of what we are told is "true" is really baseless.
At Fitness Watch we separate fitness information from fitness noise.
Friday, February 05, 2010
Anti-Obesity Drug Banned In Europe
Not yet.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.